AstraZeneca shares down 2% after report it approached Gilead over tie-up

AstraZeneca shares down 2% after report it approached Gilead over tie-up
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo (Reuters) – Shares in Britain’s AstraZeneca (AZN.L) fell 2.1% in early trades on Monday after a report it had approached U.S. rival Gilead Sciences (GILD.O) about... Read More

AstraZeneca contacted Gilead over potential megamerger: Bloomberg News

AstraZeneca contacted Gilead over potential megamerger: Bloomberg News
LONDON (Reuters) – Britain’s AstraZeneca (AZN.L) has approached U.S. rival Gilead Sciences (GILD.O) about a possible merger to form one the world’s largest drug companies, Bloomberg News reported on Sunday, citing people familiar with the matter. FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients... Read More

AstraZeneca approached Gilead about potential merger – Bloomberg News

AstraZeneca approached Gilead about potential merger – Bloomberg News
FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File Photo (Reuters) – AstraZeneca Plc (AZN.L) has approached rival drugmaker Gilead Sciences Inc (GILD.O)... Read More

AstraZeneca approaches Gilead about potential merger – Bloomberg News

AstraZeneca approaches Gilead about potential merger – Bloomberg News
FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease (COVID-19), during the outbreak of the coronavirus disease (COVID-19), in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake/File Photo (Reuters) – AstraZeneca Plc (AZN.L) has approached rival drugmaker Gilead Sciences Inc (GILD.O)... Read More

U.S. court blocks sales of Bayer weed killer

U.S. court blocks sales of Bayer weed killer
(Reuters) – Bayer AG (BAYGn.DE) has been blocked from selling an agricultural weed killer in the United States, the latest setback for a business already fighting an expensive legal battle over another product. FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File... Read More

U.S. court blocks sales of Bayer’s weed killer

U.S. court blocks sales of Bayer’s weed killer
(Reuters) – German agrochemicals group Bayer AG (BAYGn.DE) has been blocked from selling its dicamba-based weed killer in the United States after an appeals court rejected a federal regulator’s permit for the product. FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File... Read More

U.S. court blocks sales of Bayer’s dicamba herbicide

U.S. court blocks sales of Bayer’s dicamba herbicide
FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo (Reuters) – German agrochemicals group Bayer AG has been blocked from selling its dicamba herbicide in the United States after an appeals court rejected a federal regulator’s permit for the product. The... Read More

California court hears appeal of $289 million verdict against Bayer in first Roundup cancer trial

California court hears appeal of $289 million verdict against Bayer in first Roundup cancer trial
(Reuters) – A California appeals court on Tuesday heard arguments in the first case that went to trial over allegations that Bayer AG’s glyphosate-based weed killer Roundup causes cancer, resulting in a $289 million judgment against the company. FILE PHOTO: A bridge is decorated with the logo of a Bayer AG, a German pharmaceutical and chemical maker in Wuppertal, Germany... Read More